tailieunhanh - Ebook Clinical assessment of voice (2E): Part 1

(BQ) Part 1 book “Clinical assessment of voice” has contents: Patient history, special considerations relating to members of the acting profession, physical examination, the clinical voice laboratory, high-speed digital imaging, laryngeal electromyography, and other contents. | Clinical Assessment of Voice Second Edition Clinical Assessment of Voice Second Edition Robert Thayer Sataloff, md, dma 5521 Ruffin Road San Diego, CA 92123 e-mail: info@ Website:  Copyright © 2017 by Plural Publishing, Inc. Typeset in 10/12 Palatino by Flanagan’s Publishing Service, Inc. Printed in Korea by Four Colour Print Group. All rights, including that of translation, reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, recording, or otherwise, including photocopying, recording, taping, Web distribution, or information storage and retrieval systems without the prior written consent of the publisher. For permission to use material from this text, contact us by Telephone:  (866) 758-7251 Fax:  (888) 758-7255 e-mail: permissions@ Every attempt has been made to contact the copyright holders for material originally printed in another source. If any have been inadvertently overlooked, the publishers will gladly make the necessary arrangements at the first opportunity. NOTICE TO THE READER Care has been taken to confirm the accuracy of the indications, procedures, drug dosages, and diagnosis and remediation protocols presented in this book and to ensure that they conform to the practices of the general medical and health services communities. However, the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the information in this book and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of the contents of the publication. The diagnostic and remediation protocols and the medications described do not necessarily have specific approval by the Food and Drug administration for use in the disorders and/or diseases and dosages for which they are recommended. Application of this .